MedTrace Logo

Myocardial Infarction Register of the Saarland

NCT02961985 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 455

Last updated 2023-04-14

No results posted yet for this study

Summary

The Myocardial Infarction Register Saarland (MIR-SL), is intended to collect data about the treatment of patients suffering from ST-elevation myocardial infarction (STEMI). It aims to provide current data on the implementation of guidelines for both, the interventional and adjuvant drug therapy of STEMI in daily clinical practice in the Saarland.

Conditions

Sponsors & Collaborators

  • Ministry of Social Affairs, Health, Women and Family of Saarland

    collaborator UNKNOWN

  • Stiftung Institut fuer Herzinfarktforschung

    lead OTHER

Principal Investigators

  • Anselm K. Gitt, Dr. · Stiftung Institut fuer Herzinfarktforschung

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2018-07-19
Completion
2023-03-29

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02961985 on ClinicalTrials.gov